Abate AS Industries Launches Kerala's First Alcon Vision Suite at Eye Hospital

2 min read     Updated on 24 Mar 2026, 08:19 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Abate AS Industries Ltd launched Kerala's first Alcon Vision Suite (AVS) at Abate Eye Hospital on 24th March 2025, introducing advanced ophthalmic technology featuring NGENUITY® 1.5 3D Visualization System and ADi digital surgical planning platform. The integrated digital ecosystem enhances surgical precision, efficiency, and patient outcomes in cataract and glaucoma surgeries while supporting medical training. This milestone positions Abate Eye Hospital as a regional leader in cutting-edge eye care technology, serving an international patient base across Europe, GCC, and Africa.

powered bylight_fuzz_icon
35909380

*this image is generated using AI for illustrative purposes only.

Abate AS Industries Ltd has announced a significant technological advancement with the launch of the Alcon Vision Suite (AVS) at Abate Eye Hospital, marking the first installation of this sophisticated ophthalmic technology in Kerala. The announcement was made on 24th March 2025, positioning the hospital at the forefront of advanced eye care in the region.

Revolutionary Technology Integration

The Alcon Vision Suite represents a comprehensive digital ecosystem designed to transform ophthalmic care delivery. The system seamlessly connects and synchronizes every stage of the surgical journey, from initial diagnostics through surgical planning to operating room visualization and postoperative care.

Key Component Technology Benefits
Visualization System NGENUITY® 1.5 3D Superior clarity, enhanced depth perception, improved ergonomics
Surgical Planning ADi Digital Platform Precise and personalized preoperative planning
Integration Full Digital Ecosystem Enhanced precision, efficiency, and patient outcomes

Advanced Features and Capabilities

The AVS installation brings several breakthrough capabilities to Kerala's ophthalmic care landscape:

  • Advanced 3D visualization for enhanced surgical accuracy
  • Personalized digital surgical planning capabilities
  • Reduced variability and improved refractive outcomes
  • Greater operating room efficiency
  • More predictable and tailored patient results
  • Enhanced training capabilities for young ophthalmologists

Leadership Vision and Strategic Impact

Mr. Arikuzhiyan Samsudeen, Chairman and Non-Executive Director, emphasized the transformative nature of this technology implementation. He stated that healthcare is entering a new era where precision, predictability, and patient experience are driven by technology. The introduction of Kerala's first Alcon Vision Suite represents a redefinition of the entire ophthalmic care journey, reflecting the organization's commitment to bringing world-class, technology-led eye care to patients while empowering the next generation of ophthalmologists.

Clinical Applications and Benefits

The AVS technology enables significant improvements in cataract and glaucoma surgeries, providing more accurate, efficient, and patient-focused care. This technological leap strengthens Abate Eye Hospital's position as a center of excellence in ophthalmology, supporting both advanced patient care and comprehensive medical training programs.

Application Area Impact
Cataract Surgery Enhanced precision and predictable outcomes
Glaucoma Treatment Improved surgical accuracy and efficiency
Medical Training Advanced learning platform for ophthalmologists
Patient Care Superior treatment experience and results

Organizational Profile and Global Reach

Abate AS Industries operates as a publicly listed eye care and education institution, building an integrated ophthalmology ecosystem that combines advanced clinical care with talent development. The organization delivers technology-enabled ophthalmic services through experienced specialists, state-of-the-art diagnostic and surgical technology, and maintains a strong commitment to patient-centered care.

The institution serves a growing international patient base spanning Europe, the GCC, and Africa, continuously expanding its reputation for reliable, high-quality treatment while maintaining strong governance standards as a listed healthcare company. Beyond clinical services, the organization integrates education and training to strengthen the pipeline of skilled eye care professionals, building a sustainable ecosystem that advances patient care and drives long-term institutional growth.

Historical Stock Returns for Abate AS Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+3.32%-2.46%-4.88%-28.17%-40.23%+19.05%

Will Abate AS Industries plan to expand the Alcon Vision Suite technology to other hospitals across India or internationally?

How might this technological advancement impact Abate AS Industries' competitive positioning and market share in the ophthalmology sector?

What revenue growth projections can investors expect from the enhanced surgical capabilities and potential increase in international patient volume?

ABATE AS Industries Promoter Group Increases Shareholding to 1.16% Through Open Market Purchase

1 min read     Updated on 10 Mar 2026, 05:31 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Al Salama Eye Research Foundation, a promoter group entity of ABATE AS Industries Limited, has increased its shareholding from 0.86% to 1.16% through the acquisition of 4,72,349 equity shares worth ₹51,68,825. The open market purchases were executed on March 5-6, 2026, through BSE, with the disclosure made under SEBI regulations on March 9, 2026. This transaction demonstrates the promoter group's continued confidence in the company.

powered bylight_fuzz_icon
34689664

*this image is generated using AI for illustrative purposes only.

ABATE AS Industries Limited has announced that Al Salama Eye Research Foundation, a promoter group entity, has increased its shareholding in the company through open market purchases. The transaction was disclosed under Regulation 7(2) of the SEBI Prohibition of Insider Trading Regulations, 2015.

Transaction Details

The promoter group entity executed a significant equity purchase over two days in March 2026. The acquisition demonstrates continued confidence from the promoter group in the company's prospects.

Parameter: Details
Acquiring Entity: Al Salama Eye Research Foundation
Transaction Type: Open Market Purchase
Shares Acquired: 4,72,349 equity shares
Transaction Value: ₹51,68,825
Transaction Dates: March 5-6, 2026
Exchange: BSE

Shareholding Changes

The acquisition resulted in a notable increase in the promoter group's stake in ABATE AS Industries. The foundation's shareholding percentage increased by 30 basis points following the transaction.

Shareholding Status: Before Transaction After Transaction Change
Number of Shares: 13,61,334 18,33,683 +4,72,349
Percentage Holding: 0.86% 1.16% +0.30%

Regulatory Compliance

The company has fulfilled its regulatory obligations by disclosing the transaction details to BSE Limited. Key compliance aspects include:

  • Disclosure made under SEBI Prohibition of Insider Trading Regulations, 2015
  • Intimation provided to the company on March 9, 2026
  • Form-C filing completed with all required transaction details
  • No derivative trading reported in connection with this transaction

About Al Salama Eye Research Foundation

Al Salama Eye Research Foundation, the acquiring entity, is based in Perinthalamanna, Kerala. The foundation holds promoter group status in ABATE AS Industries Limited and is represented by Asharaf Samsudeen A. The entity's increased investment reflects its continued commitment to the company's growth trajectory.

The transaction was completed entirely through open market purchases on BSE, ensuring transparency and adherence to market regulations. The disclosed value excludes taxes, brokerage, and other charges as per standard reporting practices.

Historical Stock Returns for Abate AS Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+3.32%-2.46%-4.88%-28.17%-40.23%+19.05%

More News on Abate AS Industries

1 Year Returns:-40.23%